News from biopharmadive.comFollowNews from biopharmadive.comSee all of biopharmadive.com news coverage in one place. Discover how biopharmadive.com’s media bias informs their coverage and compare with thousands of other news outlets.Overall, we’ve indexed 247 stories from biopharmadive.com over the past 3 months. The Ground News media bias check for biopharmadive.com is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. biopharmadive.com’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.Follow See all of biopharmadive.com news coverage in one place. Discover how biopharmadive.com’s media bias informs their coverage and compare with thousands of other news outlets. Overall, we’ve indexed 247 stories from biopharmadive.com over the past 3 months. The Ground News media bias check for biopharmadive.com is Center. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. biopharmadive.com’s aggregated factuality score is High. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check. Information about biopharmadive.comWhere is biopharmadive.com located?biopharmadive.com's WebsiteMedia Bias RatingsAverage Bias Rating:CenterCenterbyMedia Bias/Fact CheckDo you diasgree? Edit biasLearn more about Media Bias Ratings.FactualityAverage Factuality Rating: HighHighbyMedia Bias/Fact CheckLearn more about Factuality Ratings.Top biopharmadive.com NewsDonald Trump · United StatesTrump picks Dr. Marty Makary, a Johns Hopkins surgeon, for FDA chief63% Center coverage: 87 sourcesU.S. president-elect Donald Trump has nominated surgeon and writer Marty Makary to lead the U.S. Food and Drug Administration, the world's most influential drug regulator with a more than $7 billion budget. See the StoryPfizer names Chris Boshoff as new R&D chief, WSJ reports75% Center coverage: 4 sources(Reuters) – Pfizer has named company veteran Chris Boshoff, who led the drugmaker’s cancer research and marketing for more than a year, as its R&D chief, WSJ reported on Wednesday. (Reporting by Sriparna Roy in Bengaluru; Editing by Shinjini Ganguli)See the StoryFDABridgeBio heart drug approved by FDA, setting up battle with Pfizer67% Center coverage: 3 sourcesThe approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market that investors have been skeptical BridgeBio can win.See the StoryLatest News StoriesTopics Most Covered by biopharmadive.comStartupsVaccinesMerckAstraZenecaMedicalStartupsVaccinesMerckSources Covering Similar TopicsEndpoints NewsSTATramaonhealthcare.comMedCity Newscontractpharma.comEndpoints NewsSTATramaonhealthcare.comSuggest a sourceLooking for a source we don't already have? Suggest one here.You've scrolled to the bottom of the feed, there are no more stories.
